Eyecare pharmaceutical company Harrow announced this week that it would offer $250 million in debt financing via senior unsecured notes due in 2030.

In addition, Harrow announced that Fifth Third Bank is expected to provide for up to a $40 million revolving credit facility, according to a press release.